Updated practice guideline for dual-energy X-ray absorptiometry (DXA)
- PMID: 39316095
- PMCID: PMC11732917
- DOI: 10.1007/s00259-024-06912-6
Updated practice guideline for dual-energy X-ray absorptiometry (DXA)
Abstract
The introduction of dual-energy X-ray absorptiometry (DXA) technology in the 1980s revolutionized the diagnosis, management and monitoring of osteoporosis, providing a clinical tool which is now available worldwide. However, DXA measurements are influenced by many technical factors, including the quality control procedures for the instrument, positioning of the patient, and approach to analysis. Reporting of DXA results may be confounded by factors such as selection of reference ranges for T-scores and Z-scores, as well as inadequate knowledge of current standards for interpretation. These points are addressed at length in many international guidelines but are not always easily assimilated by practising clinicians and technicians. Our aim in this report is to identify key elements pertaining to the use of DXA in clinical practice, considering both technical and clinical aspects. Here, we discuss technical aspects of DXA procedures, approaches to interpretation and integration into clinical practice, and the use of non-bone mineral density measurements, such as a vertebral fracture assessment, in clinical risk assessment.
Keywords: Dual-energy X-ray absorptiometry (DXA); Practice guideline; Procedures.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Disclosures: RHJAS: Unrestricted research grants of Pfizer and Siemens Healthineers; MP: None ; DSA: None; AB: Speaker/Consulting fee, GE Healthcare; OB: None; PC: None ; JJC: None ; AC: None; JC: None; KE: None; PAE: None; NCH: None; DK: None; WFL: Speakers fee/advisory Boards: UCB, Amgen, Galapagos, Pfizer; EML: Amgen: investigator, consultant, speaker; Radius: investigator, consultant, speaker; Kyowa Kirin: consultant, speaker; Ultragenyx: investigator; Angitia: consultant; Ascendis: consultant; UpTo Date: royalties; SM: None; KFM: None; CO: None; LP: None; YR: Speaker: Amgen, Dawoong; Investigator: Amgen, Kyowa Kirin, Dongguk, Dong-A, Daewoong; BR: None; JTS: None; CS: None; KAW: None; TVW:none; JTZ: None; AAK: Speaker, advisory board (Alexion, Amgen); Speaker, advisory board, research funding (Ascendis); Advisory board, research funding (Takeda); Research funding (Amolyt, Calcilytix). Ethical approval: This article does not contain any studies with human participants or animals performed by any of the authors. Competing interests: RHJAS is Associate Editor of the EJNMMI.
Figures










Similar articles
-
Bone health in childhood and adolescence: an overview on dual-energy X-ray absorptiometry scanning, fracture surveillance and bisphosphonate therapy for low-middle-income countries.Front Endocrinol (Lausanne). 2023 Apr 17;14:1082413. doi: 10.3389/fendo.2023.1082413. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37139332 Free PMC article. Review.
-
Common errors in dual-energy X-ray absorptiometry scans in imaging centers in Ecuador.Arch Osteoporos. 2020 Jan 2;15(1):6. doi: 10.1007/s11657-019-0673-3. Arch Osteoporos. 2020. PMID: 31897808
-
Dual-energy X-ray absorptiometry bone densitometry and pitfalls in the assessment of osteoporosis: a primer for the practicing clinician.Arch Osteoporos. 2020 Aug 24;15(1):135. doi: 10.1007/s11657-020-00808-2. Arch Osteoporos. 2020. PMID: 32833113
-
Optimizing DXA to Assess Skeletal Health: Key Concepts for Clinicians.J Clin Endocrinol Metab. 2020 Dec 1;105(12):dgaa632. doi: 10.1210/clinem/dgaa632. J Clin Endocrinol Metab. 2020. PMID: 32894765 Review.
-
The value of calcaneal bone mass measurement using a dual X-ray laser Calscan device in risk screening for osteoporosis.Clinics (Sao Paulo). 2009;64(8):757-62. doi: 10.1590/S1807-59322009000800008. Clinics (Sao Paulo). 2009. PMID: 19690659 Free PMC article. Clinical Trial.
Cited by
-
Association between immune-inflammatory index and osteoporosis: a systematic review and meta-analysis.Eur J Med Res. 2025 Jul 16;30(1):632. doi: 10.1186/s40001-025-02893-w. Eur J Med Res. 2025. PMID: 40665418 Free PMC article.
-
Hip Fractures: Clinical, Biomaterial and Biomechanical Insights into a Common Health Challenge.Bioengineering (Basel). 2025 May 28;12(6):580. doi: 10.3390/bioengineering12060580. Bioengineering (Basel). 2025. PMID: 40564397 Free PMC article. Review.
-
The Early Detection of Osteoporosis Through the Measurement of Hard Palate Thickness (HPT) Using Dental Cone Beam Computed Tomography (CBCT): A New Indicator for Osteoporosis?Diagnostics (Basel). 2025 Jun 25;15(13):1603. doi: 10.3390/diagnostics15131603. Diagnostics (Basel). 2025. PMID: 40647602 Free PMC article.
-
Interpretable Machine Learning for Osteopenia Detection: A Proof-of-Concept Study Using Bioelectrical Impedance in Perimenopausal Women.J Funct Morphol Kinesiol. 2025 Jul 11;10(3):262. doi: 10.3390/jfmk10030262. J Funct Morphol Kinesiol. 2025. PMID: 40700198 Free PMC article.
-
Characteristics of changes in bone mineral density and body composition in obesity patients after metabolic and bariatric surgery: A prospective cohort study.Diabetes Obes Metab. 2025 Sep;27(9):4968-4977. doi: 10.1111/dom.16543. Epub 2025 Jun 25. Diabetes Obes Metab. 2025. PMID: 40566747 Free PMC article.
References
-
- Nih Consensus Development Panel on Osteoporosis Prevention, Therapy D. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285(6):785–95. - PubMed
-
- Khan AA, Slart RHJA, Ali DS, Bock O, Carey JJ, Camacho P et al. Osteoporotic Fractures: Diagnosis, Evaluation and Significance from the International Working Group on DXA Best Practice - First of a Six-Part Series on DXA Best Practices. Mayo Clin Proc. 2024. - PubMed
-
- ISCD. Adult Official Positions of the ISCD; 2019. https://www.iscdorg/official-positions/2019-iscd-official-positions-adult
-
- ISCD. Adult Official Positions of the ISCD as updated in 2023; 2023. https://www.iscdorg/official-positions-2023.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources